Prior Axitinib as a Determinant of Outcome of Renal Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Clear Cell Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Diagnostic Imaging for Clear Cell Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE2
Investigator-Initiated Trial of Combined Ipilimumab, Nivolumab and Stereotactic Radiation in Patients With Metastatic Clear-Cell RCC (ccRCC) Who Have Failed Treatment With Single-Agent Nivolumab
- Status
- WITHDRAWN
- Phase
- PHASE2
MK-3795 (PT2385) for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma (MK-3795-003)
- Status
- COMPLETED
- Phase
- PHASE2
Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Addition of X4P-001 to Nivolumab Treatment in Participants With Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Enzalutamide Before Surgery in Treating Patients With Kidney Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors
- Status
- COMPLETED
- Phase
- PHASE2
Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety Study of MGD009 in B7-H3-expressing Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab in Treating Patients With High-Risk Kidney Cancer Before Surgery
- Status
- TERMINATED
- Phase
- PHASE1
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2